Research and Clinical Trials
Return to IBD, Dysplasia and Cancer Overview
More on IBD, Dysplasia and Cancer
Clinical Services
Return to IBD, Dysplasia and Cancer Overview
More on IBD, Dysplasia and Cancer
- Autoimmune Hepatitis
- Biliary Cancer
- Cirrhosis
- Digestive Diseases
- Digestive System Cancers
- Functional Dyspepsia
- Gallbladder Disease
- Gastrointestinal Cancer
- General Surgery
- Hepatitis B
- Hepatitis C
- Inflammatory Bowel Disease (IBD): Ulcerative Colitis, Crohn's Disease
- Innovative Procedures
- Irritable Bowel Syndrome
- Liver Cancer
- Liver Diseases
- Pancreatic Cancer
- Pancreatitis
- Peptic Ulcer Disease
- Portal Hypertension
- Preventive Medicine and Nutrition
- Primary Biliary Cirrhosis (PBC)
- Primary Sclerosing Cholangitis
- Stomach (Gastric) Cancer
- Stomach Diseases
- Symptoms and Risk Factors for Irritable Bowel Syndrome
Digestive Diseases
IBD, Dysplasia and Cancer
Back to the nypdigestive.org Home Page
Inflammatory bowel disease is associated with an increased lifetime risk for colorectal cancer.
Over time, the inflammation in the gastrointestinal tract can lead to abnormal changes in the cells called dysplasia, which are a warning sign of cancer.
While the majority of patients with IBD will never develop colorectal cancer, it is important to attend your regular checkups so that your doctor can screen for cancer.
Contact
- Digestive and Liver Diseases, NewYork-Presbyterian/Columbia
-
Directions
(212) 305-1909
- Gastroenterology and Hepatology, NewYork-Presbyterian/Weill Cornell
-
Directions
(646) 962-4463
Click the button above or call
1 877 NYP WELL
